Showing results (341-350 of 3,015) with videos related to
Sort By:
Pageof 302
Current Drug Targets|April 6, 2018
Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via OsteocyteTiantian Wang, Xijie Yu, Chengqi HeCurrent Drug Targets|May 17, 2018
Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD)Lifeng Wang, Junhua Chen, Chao Ning, et al.Current Drug Targets|May 4, 2017
Personalizing Psychological Treatment Along the IBD Journey: From Diagnosis to SurgeryJulia Menichetti, Gionata Fiorino, Elena VegniCurrent Drug Targets|April 27, 2017
Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?Ismaliza Ismail, Suzaily Wahab, Hatta Sidi, et al.Current Drug Targets|May 10, 2017
Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer TherapyAfshin Babazadeh, Mahdi Zeinali, Hamed HamishehkarCurrent Drug Targets|May 27, 2017
Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized ApproachParambir S Dulai, Corey A SiegelCurrent Drug Targets|July 6, 2017
Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of OsteoporosisSohyea Kwon, Anne H Wang, Cheryl A Sadowski, et al.Current Drug Targets|April 7, 2018
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic EffectsNaisargee Patel, Rajeev K Tyagi, Nikunj Tandel, et al.Current Drug Targets|April 7, 2018
ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's DiseaseWei Chen, Fengzhong Jin, Guihua Cao, et al.Current Drug Targets|August 26, 2016
A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug TargetsKamlesh SharmaPageof 302